国药股份
(600511)
| 流通市值：149.68亿 | | | 总市值：204.09亿 |
| 流通股本：5.53亿 | | | 总股本：7.55亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 26,728,336,667.88 | 13,555,320,492.97 | 52,468,280,576.72 | 39,381,301,380.27 |
| 营业总成本 | 25,739,069,606.32 | 13,016,129,612.77 | 50,383,129,082.29 | 37,808,187,653.76 |
| 其他经营收益 | | | | |
| 营业利润 | 1,170,833,913.38 | 606,590,612.27 | 2,621,664,012.24 | 1,945,535,747.92 |
| 利润总额 | 1,142,820,862 | 606,781,074.39 | 2,600,142,573.34 | 1,933,742,465.13 |
| 净利润 | 874,248,629.54 | 491,514,664.76 | 2,089,403,586 | 1,555,894,465.78 |
| 每股收益 | | | | |
| 其他综合收益 | -10,608,986.42 | 27,155,628.34 | 23,638,059.9 | 25,861,163.15 |
| 综合收益总额 | 863,639,643.12 | 518,670,293.1 | 2,113,041,645.9 | 1,581,755,628.93 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 31,423,454,109.83 | 31,311,243,404.89 | 31,991,463,386.09 | 30,528,913,480.03 |
| 非流动资产: | | | | |
| 非流动资产合计 | 4,616,403,464.59 | 4,864,964,735.13 | 4,693,560,596.5 | 4,596,247,754.96 |
| 资产总计 | 36,039,857,574.42 | 36,176,208,140.02 | 36,685,023,982.59 | 35,125,161,234.99 |
| 流动负债: | | | | |
| 流动负债合计 | 14,429,589,073.82 | 14,354,668,111.24 | 15,402,138,852.08 | 14,200,537,627.23 |
| 非流动负债: | | | | |
| 非流动负债合计 | 1,042,007,529.35 | 994,646,009.15 | 974,661,403.98 | 993,902,979.98 |
| 负债合计 | 15,471,596,603.17 | 15,349,314,120.39 | 16,376,800,256.06 | 15,194,440,607.21 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 18,810,277,656.74 | 19,046,139,042.12 | 18,544,719,561.48 | 18,042,614,851.34 |
| 股东权益合计 | 20,568,260,971.25 | 20,826,894,019.63 | 20,308,223,726.53 | 19,930,720,627.78 |
| 负债和股东权益合计 | 36,039,857,574.42 | 36,176,208,140.02 | 36,685,023,982.59 | 35,125,161,234.99 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 27,525,002,710.73 | 12,127,754,743.45 | 57,325,496,880.79 | 40,190,830,933.23 |
| 经营活动现金流出小计 | 30,159,346,259.48 | 15,720,705,538.85 | 55,319,979,368.73 | 42,241,263,715.34 |
| 经营活动产生的现金流量净额 | -2,634,343,548.75 | -3,592,950,795.4 | 2,005,517,512.06 | -2,050,432,782.11 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 549,099,108.3 | 3,099,356.07 | 50,805,688.96 | 32,545,348.47 |
| 投资活动现金流出小计 | 29,269,085.95 | 6,420,132.8 | 68,194,378.17 | 40,419,863.94 |
| 投资活动产生的现金流量净额 | 519,830,022.35 | -3,320,776.73 | -17,388,689.21 | -7,874,515.47 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 216,000,000 | 106,000,000 | 319,447,721.2 | 319,447,721.2 |
| 筹资活动现金流出小计 | 852,672,633.2 | 192,664,302.09 | 1,706,924,328.71 | 1,395,528,475.2 |
| 筹资活动产生的现金流量净额 | -636,672,633.2 | -86,664,302.09 | -1,387,476,607.51 | -1,076,080,754 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -2,751,186,159.6 | -3,682,935,874.22 | 600,652,215.34 | -3,134,388,051.58 |
| 期末现金及现金等价物余额 | 6,140,860,112.7 | 5,209,110,398.08 | 8,892,046,272.3 | 5,157,006,005.38 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -2,751,186,159.6 | - | 600,652,215.34 | - |
最新报告期：2026-08-28| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中信建投 | 刘若飞,沈兴熙,贺菊颖 | 2.65 | 2.81 | 2.99 | 2026-08-28 |
| 中金公司 | 夏璐,张琎,朱言音 | 2.88 | 3.15 | -- | 2026-08-21 |
| 华泰证券 | 代雯,孔垂岩,王殷杰 | 2.68 | 2.75 | 2.83 | 2026-08-20 |